Elution-stabilized preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9572806
APP PUB NO 20120276166A1
SERIAL NO

13516672

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a solid preparation which does not undergo the delay of elution of the active ingredient even after long-term storage. The solid preparation independently contains a teneligliptin-containing part containing teneligliptin or a salt thereof, or a solvate of teneligliptin or the salt thereof, in an amount 1.5- to 10-fold larger than that desired for the solid preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MITSUBISHI TANABE PHARMA CORPORATIONOSAKA-SHI OSAKA 541-8505

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abe, Hidaka Osaka, JP 1 0
Obayashi, Yasuaki Osaka, JP 1 0
Yasui, Shinichiro Aichi, JP 16 272

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00